Discover the Benefits of Adoptive Cell Transfer Therapy With Tumor-Infiltrating Lymphocytes
Beijing BIOOCUS Biotech Ltd. is proud to present its revolutionary Adoptive Cell Transfer Therapy with Tumor-Infiltrating Lymphocytes. This cutting-edge therapy utilizes a patient's own immune cells, known as tumor-infiltrating lymphocytes (TILs), to target and destroy cancer cells. The process begins with the extraction of TILs from the patient's tumor, which are then isolated, multiplied, and activated in our state-of-the-art laboratory. Once the TILs have been expanded to sufficient numbers, they are infused back into the patient where they can recognize and attack the cancerous cells
- Basal Cell Lymphoma Products
- Basal Cell Lymphoma Product
- Basal Cell Lymphoma Service
- Lung Cancer Mortality Rate Company
- Lung Cancer Mortality Rate Companies
- Lung Cancer Mortality Rate Products
- Lung Cancer Mortality Rate Product
- Lung Cancer Mortality Rate Service
- Beta Cell Lymphoma Company
- Beta Cell Lymphoma Companies